Pharming Group NV
XBER:PHGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pharming Group NV
XBER:PHGN
|
NL |
|
A
|
Aeon Co Ltd
XMUN:JUS1
|
JP |
|
Ryanair Holdings PLC
ISEQ:RYA
|
IE |
|
D
|
Diebold Nixdorf Inc
XETRA:DBD
|
US |
|
CorMedix Inc
NASDAQ:CRMD
|
US |
|
DIRTT Environmental Solutions Ltd
OTC:DRTTF
|
CA |
|
M
|
Morixe Hermanos SACI
BCBA:MORI
|
AR |
|
Keyence Corp
TSE:6861
|
JP |
|
T
|
TeamLease Services Ltd
BSE:539658
|
IN |
|
Swatch Group AG
OTC:SWGAF
|
CH |
|
K
|
Keyence Corp
XMUN:KEE
|
JP |
|
Novus Holdings Ltd
F:N09
|
ZA |
|
I
|
Itochu Corp
F:IOC
|
JP |
|
K
|
Kimberly-Clark Corp
F:KMY
|
US |
|
E
|
Elanco Animal Health Inc
XETRA:5EA
|
US |
|
Klepierre SA
PAR:LI
|
FR |
|
C
|
Caterpillar Inc
SIX:CAT
|
US |
|
Dish TV India Ltd
OTC:DTTVY
|
IN |
|
Travelers Companies Inc
NYSE:TRV
|
US |
Bankruptcy Probability
Pharming Group NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pharming Group NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
Pharming Group NV
AEX:PHARM
|
828m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
438.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
194.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pharming Group NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pharming Group NV has total debt of 107.1m USD. This includes both short-term (0 USD) and long-term (107.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
